Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RO1 CA214871, RO1 CA214871)
U.S. Department of Health & Human Services | National Institutes of Health
Received: 7 August 2020
Accepted: 17 August 2021
First Online: 10 September 2021
: S. Moulder has partial support for clinical trials from Pfizer, Genetech, Seattle Genetics, Lilly, Merck, EMDSerono, Bayer, AstraZeneca and Novartis, and no other conflict of interest. All other authors have affirmed no conflict of interest.